Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Short-term Investments (2020 - 2025)

NeuroPace has reported Short-term Investments over the past 6 years, most recently at $39.4 million for Q4 2025.

  • Quarterly results put Short-term Investments at $39.4 million for Q4 2025, changed 0.1% from a year ago — trailing twelve months through Dec 2025 was $39.4 million (changed 0.1% YoY), and the annual figure for FY2025 was $39.4 million, changed 0.1%.
  • Short-term Investments for Q4 2025 was $39.4 million at NeuroPace, roughly flat from $39.4 million in the prior quarter.
  • Over the last five years, Short-term Investments for NPCE hit a ceiling of $96.7 million in Q3 2021 and a floor of $16.7 million in Q1 2021.
  • Median Short-term Investments over the past 5 years was $50.0 million (2023), compared with a mean of $59.1 million.
  • Biggest five-year swings in Short-term Investments: skyrocketed 724.68% in 2021 and later plummeted 36.36% in 2023.
  • NeuroPace's Short-term Investments stood at $96.4 million in 2021, then dropped by 26.55% to $70.8 million in 2022, then crashed by 31.65% to $48.4 million in 2023, then dropped by 18.74% to $39.3 million in 2024, then grew by 0.1% to $39.4 million in 2025.
  • The last three reported values for Short-term Investments were $39.4 million (Q4 2025), $39.4 million (Q3 2025), and $39.3 million (Q2 2025) per Business Quant data.